Banque Cantonale Vaudoise’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-622
Closed -$2K 893
2025
Q4
$2K Hold
622
﹤0.01% 811
2025
Q3
$3K Sell
622
-1,516
-71% -$6.66K ﹤0.01% 804
2025
Q2
$11K Hold
2,138
﹤0.01% 750
2025
Q1
$9K Buy
+2,138
New +$10K ﹤0.01% 804
2024
Q3
$15K Hold
2,138
﹤0.01% 708
2024
Q2
$17K Hold
2,138
﹤0.01% 907
2024
Q1
$15K Buy
+2,138
New +$14.1K ﹤0.01% 910
2022
Q1
Sell
-16,302
Closed -$533K 1340
2021
Q4
$533K Buy
+16,302
New +$656K 0.02% 566

Other funds holding GDRX

Banque Cantonale Vaudoise's GDRX Position: Q1 2026 in Review

Banque Cantonale Vaudoise sold out of GoodRx Holdings (GDRX) in Q1 2026, closing a stake of 622 shares — an estimated $2K sold.

Banque Cantonale Vaudoise first reported a position in GDRX in Q4 2021 and held it in 8 quarters. The position peaked at $533K in Q4 2021. 174 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.

  • Banque Cantonale Vaudoise reported no remaining GoodRx Holdings position as of Q1 2026 after selling out during the quarter.
  • Banque Cantonale Vaudoise sold 622 GoodRx Holdings shares in Q1 2026, an estimated $2K.
  • Banque Cantonale Vaudoise first reported a position in GoodRx Holdings in Q4 2021 and held it in 8 quarters.
  • Banque Cantonale Vaudoise's GoodRx Holdings position peaked at $533K in Q4 2021.
  • 174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.

Based on Banque Cantonale Vaudoise's 13F filing for Q1 2026, filed 20 Apr 2026.